CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock

Clinical trial NCT05267886 · RECRUITING

Trial details

NCT number: NCT05267886
Sponsor: Ottawa Heart Institute Research Corporation
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Shock, Cardiogenic

Start date: 2022-03-05
Primary completion: 2026-12-01
Enrollment: 346

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.